Specific anti-SARS-CoV-2 S1 IgY-scFv is a promising tool for recognition of the virus

As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread globally, a series of vaccines, antibodies and drugs have been developed to combat coronavirus disease 2019 (COVID-19). High specific antibodies are powerful tool for the development of immunoassay and providing pass...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Shikun, Wu, Rao, Zhou, Tingting, Liu, Xiang, Zhu, Jin, Zhang, Xiaoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840941/
https://www.ncbi.nlm.nih.gov/pubmed/35150368
http://dx.doi.org/10.1186/s13568-022-01355-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840941/
https://www.ncbi.nlm.nih.gov/pubmed/35150368
http://dx.doi.org/10.1186/s13568-022-01355-4

Ejemplares similares